- Report
- April 2023
- 147 Pages
Global
From €5983EUR$5,999USD£4,997GBP
- Report
- April 2023
- 147 Pages
Global
From €5983EUR$5,999USD£4,997GBP
- Report
- April 2023
- 147 Pages
Global
From €5983EUR$5,999USD£4,997GBP
- Report
- April 2023
- 147 Pages
Global
From €5983EUR$5,999USD£4,997GBP
- Report
- April 2023
- 147 Pages
Global
From €5983EUR$5,999USD£4,997GBP
- Report
- February 2024
- 180 Pages
Global
From €5484EUR$5,499USD£4,581GBP
- Report
- October 2021
- 293 Pages
Global
From €4438EUR$4,450USD£3,707GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1247EUR$1,250USD£1,041GBP
- Report
- November 2023
- 190 Pages
Global
From €4488EUR$4,500USD£3,749GBP
- Report
- November 2023
- 180 Pages
Global
From €4488EUR$4,500USD£3,749GBP
- Report
- October 2023
- 188 Pages
Global
From €4488EUR$4,500USD£3,749GBP
- Report
- October 2023
- 178 Pages
Global
From €4488EUR$4,500USD£3,749GBP
- Report
- October 2023
- 190 Pages
Global
From €4488EUR$4,500USD£3,749GBP
- Report
- October 2023
- 190 Pages
Global
From €4488EUR$4,500USD£3,749GBP
- Report
- September 2023
- 83 Pages
Israel
From €3491EUR$3,500USD£2,916GBP
- Report
- September 2023
- 90 Pages
Egypt
From €3491EUR$3,500USD£2,916GBP
- Report
- April 2023
- 112 Pages
Global
From €4737EUR$4,750USD£3,957GBP
- Report
- April 2023
- 120 Pages
Global
From €4737EUR$4,750USD£3,957GBP
- Report
- April 2023
- 115 Pages
Global
From €4737EUR$4,750USD£3,957GBP
- Report
- April 2023
- 117 Pages
Global
From €4737EUR$4,750USD£3,957GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more